Global and USA Cancer Immunotherapy Market 2017-2022: This Space will be a Significant Revenue Generator … – PR Newswire (press release)
|
Global and USA Cancer Immunotherapy Market 2017-2022: This Space will be a Significant Revenue Generator …
PR Newswire (press release) reveals that the cancer immunotherapy space will be a significant revenue generator (excess of $80 billion) for the biopharmaceutical industry by 2020. The market has been supported by the approval of Bristol-Myers' Yervoy drug for melanoma, BMS's … |
